reducing equivalents from the cytosol to the mitochondria through the malate-aspartate NADH shuttle. 4 Recent results in AGC2 knockout mice suggest that the cytosolic redox potential may be important in the generation of hyperammonemia seen in type 2 citrullinemia. 5 An increased cytosolic ratio of NADH to NAD + , perhaps triggered by dietary factors such as carbohydrate or alcohol intake, could lower cytosolic aspartate concentrations and precipitate hyperammonemia.
Although well recognized in East Asia, type 2 citrullinemia has rarely been reported elsewhere. It is important to consider this diagnosis in adults presenting with hyperammonemic encephalopathy, since the management of type 2 citrullinemia is very different from the management of classic urea-cycle defects. Patients with type 2 citrullinemia should not be treated with a lowprotein diet or an emergency regimen that includes high amounts of carbohydrate. Given the dismal prognosis for this condition, patients should be referred for consideration of liver transplantation as soon as possible after their first presentation with metabolic decompensation. Giuseppe Fiermonte, Pharm.D.
